Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01602575 · ClinicalTrials.gov registry record · NA
Neuroimaging and Biomarkers in Chronic Visceral Pain
A NA study of Irritable Bowel Syndrome, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
- 1
- Study location
NCT01602575: Completed NA study of Irritable Bowel Syndrome, sponsored by University of California, Los Angeles.
NCT01602575 is a NA study of Irritable Bowel Syndrome that has completed, run by University of California, Los Angeles. The registered enrollment target is 119 participants, below the 142-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (16% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01602575, a NA study of Irritable Bowel Syndrome, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to use functional magnetic resonance imaging (fMRI) to evaluate brain resting state networks, responses to abdominal stimuli and the effect of MBSR Training on these measures. The goal of this study is to identify biomarkers of IBS and assess the responsiveness these biomarkers after MBSR Training. A biomarker, or biological marker, is in general a substance or measure used as an indicator of a biological state. It is a characteristic that is measured and evaluated as an indicator of normal biological processes, disease processes, or responses to a therapeutic intervention, in this case MBSR.
Primary Outcome
To validate optimal brain biomarker candidates by assessment of treatment responsiveness in IBS patients following and 8 week course in Mindfulness Based Stress Reduction (MBSR).
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness based Stress Reduction Training (MBSR)
Study Locations (1)
California
- Oppenheimer Center for Neurobiology of Stress - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2013-01 |
| Est. Completion | 2018-03-20 |
| Phase | NA |
What the finished NCT01602575 record still lists
NCT01602575 is an interventional study that assigns participants to a tested intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 142-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (16% lower).
The record links to 1 condition, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness based Stress Reduction Training (MBSR) is the first listed.
NCT01602575 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01602575 about?
NCT01602575 is a clinical study titled "Neuroimaging and Biomarkers in Chronic Visceral Pain". The purpose of this study is to use functional magnetic resonance imaging (fMRI) to evaluate brain resting state networks, responses to abdominal stimuli and the effect of MBSR Training on these measures. The goal of this study is to identify biomarkers of IBS and assess the responsiveness these bio...
What is the current status of trial NCT01602575?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2013-01. Estimated completion is 2018-03-20.
What conditions does trial NCT01602575 study?
This clinical trial studies the following conditions: Irritable Bowel Syndrome.
What interventions are being tested in trial NCT01602575?
The interventions under investigation include: Mindfulness based Stress Reduction Training (MBSR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01602575?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01602575 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Irritable Bowel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01602575's enrollment target sits among peer trials
119 18th of 47 higher than 30 of 47 other Irritable Bowel Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Irritable Bowel Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?
RECRUITING · NA
-
GI Alpha-Gal Study
RECRUITING · NA
-
Visible Abdominal Distension
RECRUITING · NA
-
IBS Skin Patch Test Food Allergy Study
RECRUITING · NA
-
Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome
RECRUITING · NA
-
Well-being in IBS: Strengths and Happiness (WISH) 2.0
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia